Literature DB >> 28145127

Cortisol Levels in Children With Diabetic Ketoacidosis Associated With New-Onset Type 1 Diabetes Mellitus.

Kristen M Williams1, Pamela Fazzio2, Sharon E Oberfield1, Mary P Gallagher3, Gaya S Aranoff1.   

Abstract

There is little data documenting cortisol levels in children with diabetic ketoacidosis (DKA), despite the fact that untreated adrenal insufficiency (AI) could worsen the outcome of DKA. In this cross-sectional study, we assessed serum cortisol levels in 28 children with DKA and new onset type 1 diabetes mellitus evaluated at our center over a 5-year period. Average duration of diabetes-related symptoms was positively associated with age ( P = .002), and significantly lower hemoglobin A1c levels were observed in the youngest children. The mean cortisol level was 40.9 µg/dL, with a range of 7.8 to 119 µg/dL. Cortisol levels were found to be inversely associated with serum pH ( P = .007). There was no difference in the clinical outcome of the 4 patients who had cortisol levels less than 18 µg/dL. Overall, we did not find clinical or laboratory evidence of diminished cortisol reserve; however, the possibility of AI must be kept in mind when treating children with DKA.

Entities:  

Keywords:  adrenal insufficiency; autoimmune; cortisol; diabetic ketoacidosis; type 1 diabetes mellitus

Mesh:

Substances:

Year:  2017        PMID: 28145127      PMCID: PMC5310834          DOI: 10.1177/0009922816684595

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  42 in total

Review 1.  Hyperglycemic crises in patients with diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

Review 2.  Other complications and associated conditions with diabetes in children and adolescents.

Authors:  Olga Kordonouri; Ann M Maguire; Mikael Knip; Edith Schober; Renata Lorini; Reinhard W Holl; Kim C Donaghue
Journal:  Pediatr Diabetes       Date:  2009-09       Impact factor: 4.866

3.  Complement activation in diabetic ketoacidosis and its treatment.

Authors:  Rita S Jerath; C Lynne Burek; William H Hoffman; Gregory G Passmore
Journal:  Clin Immunol       Date:  2005-07       Impact factor: 3.969

4.  Acute diabetic ketoacidosis in children: role of the stress hormones.

Authors:  M H MacGillivray; E Bruck; M L Voorhess
Journal:  Pediatr Res       Date:  1981-02       Impact factor: 3.756

5.  Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.

Authors:  Frankie B Stentz; Guillermo E Umpierrez; Ruben Cuervo; Abbas E Kitabchi
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

Review 6.  The altered adrenal axis and treatment with glucocorticoids during critical illness.

Authors:  Dieter Mesotten; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-09

Review 7.  Measurement of the glucocorticoid receptor: relevance to the diagnosis of critical illness-related corticosteroid insufficiency in children.

Authors:  Rahul Bhatia; Jonathan Muraskas; Linda Witek Janusek; Herbert Mathews
Journal:  J Crit Care       Date:  2014-02-28       Impact factor: 3.425

8.  Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes.

Authors:  Abbas E Kitabchi; Frankie B Stentz; Guillermo E Umpierrez
Journal:  Biochem Biophys Res Commun       Date:  2004-03-05       Impact factor: 3.575

9.  Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia Pediatric Diabetes Registry.

Authors:  Terri H Lipman; Lorraine E Levitt Katz; Sarah J Ratcliffe; Kathryn M Murphy; Alexandra Aguilar; Iraj Rezvani; Carol J Howe; Shruti Fadia; Elizabeth Suarez
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

10.  Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease.

Authors:  S Laureti; A De Bellis; V I Muccitelli; F Calcinaro; A Bizzarro; R Rossi; A Bellastella; F Santeusanio; A Falorni
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.